EULAV Asset Management - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.

Quarter-by-quarter ownership
EULAV Asset Management ownership history of EXELIXIS INC
ValueSharesWeighting
Q3 2023$14,202,500
+10.9%
650,000
-3.0%
0.52%
+8.8%
Q2 2023$12,803,700
-10.9%
670,000
-9.5%
0.48%
-15.7%
Q1 2023$14,363,400
-2.7%
740,000
-19.6%
0.57%
-10.6%
Q4 2022$14,756,800
+13.4%
920,000
+10.8%
0.63%
+9.9%
Q3 2022$13,014,000
-32.1%
830,000
-9.8%
0.58%
-27.1%
Q2 2022$19,154,000
-40.5%
920,000
-35.2%
0.79%
-17.5%
Q1 2022$32,191,000
-8.3%
1,420,000
-26.0%
0.96%
+8.2%
Q4 2021$35,098,000
-14.9%
1,920,000
-1.5%
0.88%
-18.7%
Q3 2021$41,223,000
+11.5%
1,950,000
-3.9%
1.09%
+11.2%
Q2 2021$36,987,000
-33.4%
2,030,000
-17.5%
0.98%
-34.3%
Q1 2021$55,571,000
+46.5%
2,460,000
+30.2%
1.49%
+50.3%
Q4 2020$37,932,000
+12.4%
1,890,000
+37.0%
0.99%
-0.4%
Q3 2020$33,741,000
+19.4%
1,380,000
+16.0%
1.00%
+7.6%
Q2 2020$28,251,000
+40.2%
1,190,000
+1.7%
0.92%
+14.8%
Q1 2020$20,147,000
+13.8%
1,170,000
+16.4%
0.81%
+31.9%
Q4 2019$17,708,000
-11.0%
1,005,000
-10.7%
0.61%
-16.8%
Q3 2019$19,896,000
-20.8%
1,125,000
-4.3%
0.73%
-22.0%
Q2 2019$25,110,000
+7.1%
1,175,000
+21.8%
0.94%
-2.6%
Q1 2019$23,449,000
+19.2%
965,000
-3.5%
0.97%
-1.7%
Q4 2018$19,670,000
+16.8%
1,000,000
+5.3%
0.98%
+36.3%
Q3 2018$16,834,000
+8.6%
950,000
+31.9%
0.72%
+1.1%
Q2 2018$15,494,000
+70.6%
720,000
+75.6%
0.71%
+64.3%
Q1 2018$9,081,000410,0000.43%
Other shareholders
EXELIXIS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 15,001,073$265,294,00064.62%
Sargent Investment Group, LLC 465,620$8,234,0003.70%
Orbimed Advisors 3,912,900$69,200,0001.31%
Bellevue Group AG 3,858,700$68,241,0001.27%
TEALWOOD ASSET MANAGEMENT INC 137,129$2,425,0001.04%
CAPITAL MANAGEMENT CORP /VA 200,995$3,555,0000.97%
Penn Capital Management Company, LLC 517,988$9,161,0000.96%
Chicago Capital, LLC 801,560$14,176,0000.95%
Portolan Capital Management 454,444$8,037,0000.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 103,534$1,830,0000.85%
View complete list of EXELIXIS INC shareholders